ARWR - Arrowhead Pharmaceuticals EPS misses by $0.77 misses on revenue November, 22 2021 04:03 PM Arrowhead Pharmaceuticals Inc. Arrowhead Pharmaceuticals (NASDAQ:ARWR): FY GAAP EPS of -$1.36 misses by $0.77. Revenue of $138.29M (+57.2% Y/Y) misses by $35.61M. Press Release For further details see: Arrowhead Pharmaceuticals EPS misses by $0.77, misses on revenue